1. Acosta D, Mitchell DB, Sorensen EMB et al. (1987) The metabolism and toxicity of xenobiotics in a primary culture system of postnatal rat hepatocytes. In: Rauckman EJ, Padilla G (eds) The isolated hepatocyte: use in toxicology and xenobiotic transformation. Academic, New York, pp 265–280
2. Amaducci L, Falcini M, Lippi A (1993) Descriptive epidemiology and risk factors for Alzheimer’s disease. In: Corain B, Iqbal K, Nicolini M et al. (eds) Alzheimer’s disease: advances in clinical and basic research. Wiley, New York, pp 105–111
3. Beaune PH, Bourdi M(1993) Autoantibodies against cytochromes P-450 in druginduced autoimmune hepatitis. Ann NY Acad Sci 685:641–645
4. Berry CL(1988) The no-effect level and optimal use of toxicity data. Regul Toxicol Pharmacol 8:385–388
5. Budinsky RA, Roberts SM, Coats EA, Adams L, Hess EV(1978) The formation of. procainamide hydroxylamine by rat and human liver microsomes. Drug Metab Dispos 1537:37–43